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Abstract
Background Perianal fistula is an abnormal communication between the anal canal and perianal skin. Hidradenitis suppurativa
(HS) is a chronic, auto-inflammatory skin disease in the intertriginous body areas, presenting with recurring abscesses, inflam-
matory nodules, and sinus tracts. The aim of this study was to determine the prevalence of HS in patients with a perianal fistula.
Methods All patients with perianal fistula visiting a specialized proctology clinic between July and September 2017 were
included and asked a validated diagnostic question for HS. Subsequently, physical examination was performed to objectively
assess the diagnosis and relevant patient characteristics.
Results In 6.6% (8/122) of patients, HS was diagnosed outside the perianal region. Four of these patients were newly diagnosed.
The fistulas in HS patients were classified as a superficial fistula (three), a blind ending fistula (two), and a transsphincteric fistula
(two). One patient had more than one type of fistula.
Conclusion The prevalence of HS in patients with a perianal fistula is at least 6.6%. This is higher than the prevalence reported in
the general European population (1%) suggesting an association between perianal fistulas and HS. We stress the importance to
screen for HS in patients with perianal fistulas in order to start appropriate anti-inflammatory treatment to reduce symptoms and
disease progression.
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Introduction
Perianal fistulas (PF) are uncommonwith an incidence varying
from 1.04–2.23 patients per 10,000 persons per year [1]. PF
are associated with considerable discomfort, morbidity, and
decreased quality of life as patients can present with perianal
pain, pruritus, bleeding, or purulent discharge [2]. Most fre-
quently a PF is the result of a cryptoglandular anorectal abscess
[3]. Other, less common causes comprise Crohn’s disease, sur-
gery, or trauma [3]. However, a fistula in the perianal region
may also be a sign of the underdiagnosed, chronic, auto-
inflammatory skin disease hidradenitis suppurativa (HS). HS
is characterized by recurrent abscesses, nodules, and draining
fistulas in the intertriginous regions such as the axillae and
inguinal areas but also the buttocks and perianal area.
Anogenital involvement is fairly common and seen in 18.8%
of HS patients [4]. The prevalence of HS in the European
general population is approximately 1% with a male to female
ratio of 1:3 [5]. The disease usually starts in the early twenties.
Smoking and obesity are well-established risk factors for HS
[5]. Even though HS is quite common and has a tremendous
impact on the quality of life, it is still is relatively unknown for
patients and physicians [6]. This results in a mean time to
diagnosis of 7.2 years after consulting 3.9 health care profes-
sionals on average [6]. Since HS and PF can be clinically
similar, the diagnosis of HS should be part of the differential
diagnosis of perianal fistula. However, unfamiliarity with this
diagnosis could mean that HS goes undiagnosed in a portion of
the perianal fistula population. Therefore, the aim of this study
was to evaluate the prevalence of HS in patients with PF.
Methods
All patients with a PF attending the specialized proctology
clinic, Proctos, in Bilthoven, the Netherlands, between July
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and September 2017 were included. A validated diagnostic
question for HS was used as a screening tool: BHave you ever
had recurrent boils in your armpits, groins or on the buttocks
except for the anus for the last six months?^ [7]. Subsequently,
all patients with a positive answer underwent physical exam-
ination of the axillary, inguinal, and perianal region to confirm
the diagnosis of HS when nodules, abscesses, or sinus tracts
were found. Subsequently, HS severity was classified accord-
ing to the three-stage Hurley classification [5, 8]. As part of
the routine care in the Proctos Clinic, all perianal fistulas were
examined using a three-dimensional endoanal ultrasound and
classified according to the Parks classification [9]. The Mann-
Whitney U tests and Fisher’s exact tests were performed to
analyze the difference between patients with perianal fistulas
with and without HS. Data were analyzed by use of SPSS
software (IBM, version 24.0). This type of study is ex-
empt from medical ethical committee approval under
Dutch law.
Results
A total of 122 patients with a PF were included. Twelve pa-
tients (9.8%) answered positively to the diagnostic HS ques-
tion. Physical examination confirmed the diagnosis in eight of
these patients, amounting to a prevalence of HS in patients
with a perianal fistula of 6.6%. Four out of eight patients had
not previously been diagnosed with HS. Patient characteristics
of patients with HS are presented in Table 1. All patients with
HS were classified as Hurley II severity due to the presence of
the perianal fistula. Four patients with HS had a positive fam-
ily history (first degree) of the disease. Skin regions affected
by HS included the perianal (n = 8), inguinal (n = 4), gluteal
(n = 3), and axillary (n = 2) areas. Three of these HS patients
presented with a superficial fistula, two with a blind ending
fistula, and two with a transsphincteric fistula. One patient had
more than one type of fistula. Patients with HS were more
frequently smokers compared with patients without HS, re-
spectively, 62.5% and 23.6% (p = 0.03). Moreover, in four
out of eight HS patients, a pilonidal sinus was present
(Table 2).
Discussion
To our knowledge, this is the first study investigating the
prevalence of HS in patients with PF. We found a prevalence
of HS to be at least 6.6%. This estimate might be higher
(9.8%) when incorporating the, possibly cases of mild, HS.
Since mild HS can go in regression, it cannot be confirmed by
physical examination. Four patients received a new diagnosis
of HS, demonstrating the underdiagnoses of this disease.
Early diagnosis of HS is important as it allows for early
treatment with anti-inflammatory medication, which may re-
duce symptoms and delay of natural disease progression.
Since the presumed prevalence of HS in the general popula-
tion is 1%, we argue that there may be an association between
HS and PF [6]. However, whether PF is the result of HS or that
PF is a distinct entity present next to HS, with a similar path-
ogenic mechanism, remains unknown. HS sinus tracts usually
do not penetrate the anal sphincter. We argue that the PF found
in the majority of our patients represent a HS-related sinus
tract rather than a separate entity. Interestingly, most patients
that were found to have HS were male. Even though HS pre-
dominantly affects women, it is known that HS with
anogenital involvement is most frequent in men [4].
Strengths of this study are the use of a validated HS diagnostic
question in combination with physical examination in order to
diagnose HS as the use of three-dimensional endoanal ultra-
sound for a more precise classification. Future research should
investigate PF in HS patients versus non-HS patients using
histology. In conclusion, we demonstrate an underdiagnosis
ofHS in patients presentingwith perianal fistulas, emphasizing
the importance of asking patients for HS symptomatology and
subsequent physical examination of the intertriginous regions.
Table 1 Characteristics of perianal fistula patients with HS
HS, n (%) 8 (6.6)
Known history of HS, n (%)
Yes 4 (93.8)
No 4 (6.3)
Family history of HS, n (%)
First degree 4 (50)
Second degree 0 (0)
No family history of HS 4 (50)
Hurley stadium, n (%)
Stadium I 0 (0)
Stadium II 8 (100)
Stadium III 0 (0)
Affected body regions, n (%)
Inguinal region 3 (37.50)
Gluteal region 2 (25)
Axillary region 1 (12.50)
Perineal region 2 (25)
Pseudocomedones, n (%)
Inguinal region 2 (25)
Gluteal region 1 (12.50)
Axillary region 2 (25.50)
Perineal region 0 (0)
Perianal fistula, n (%)
Transsphincteric (high perianal fistula) 2 (25)
More than one (high perianal fistula) 1 (12.5)
Superficial 3 (37.5)
Blind fistula 2 (25)
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Table 2 Patient characteristics perianal fistulas with or without HS
Perianal fistula with HS (n = 8) Perianal fistula without HS (n = 114) p value
Sex, n (%)
Male 6 (75) 71 (62.3)
Female 2 (25) 43 (37.7) 0.71
Age (years), median (IQR) 41.0 (36.5–47.0) 46.0 (36.3–53.5) 0.35
Age of onset HS (years), median (IQR) 40.0 (29.3–44.8) 43.0 (33.8–51.0) 0.36
Body mass index, median (IQR) 26.6 (24.2–33.2) 25.5 (23.0–27.7) 0.32
Smoker, n (%) 5 (62.5) 25 (23.6) 0.03**
Pilonidal sinus, n (%) 4 (50) 2 (1.9) 0.00001**
Fissure, n (%) 5 (62.5) 28 (27.2) 0.04**
Crohn’s disease, n (%) 1 (12.5) 2 (1.9) 0.2
In all continuous variables: Mann-Whitney U Test. Nominal variables: Fisher’s exact test
**Statistically significant result
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